心脏衰竭中的肌肉心脏再血管:一篇最先进的评论
Manasi Tannu1, Adam J Nelson2, Jennifer A Rymer1
1Division of Cardiology, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Journal of cardiac failure
|October 10, 2024
概括
患有心力衰竭和冠状动脉疾病的患者面临更高的死亡率. 重血管化的好处在心痛方面是显而易见的,但在呼吸障碍方面是不确定的,需要仔细的诊断和治疗策略.
科学领域:
- 心脏病学 心脏病学
- 心血管医学 心血管医学
- 心脏衰竭研究研究
背景情况:
- 患有心力衰竭 (HF) 和潜在冠状动脉疾病 (CAD) 的患者的死亡风险显著增加.
- 识别受益于再血管化以改善预后的HF患者是一个复杂的临床挑战.
研究的目的:
- 审查与CAD和HF同时存在的患者的结果,临床试验和治疗策略.
- 提出一种诊断和治疗算法来管理这些复杂的患者.
主要方法:
- 最先进的文献审查,重点关注CAD-HF患者的结果和临床试验.
- 开发一种临床决策算法,用于对患有CAD的HF患者进行再血管化.
主要成果:
- 重血管化通常对急性心肌梗塞或耐火性心痛等CAD占主导地位的症状有益.
- 重新血管化的预后益处对于没有急性事件或耐火性心脏病的高频率主导症状 (呼吸不良) 不太明确.
结论:
- 结构化的方法对于诊断和管理患有HF和CAD的患者至关重要.
- 拟议的算法旨在指导临床医生确定最佳的治疗策略,包括重血管化,以改善患者的治疗结果.
相关概念视频
Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Heart Failure I: Introduction
2
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2
Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure VI: Adjunct Therapies
5
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5


